Our results suggest that not HPV infection itself but p16INK4a overexpression contributes to shaping of the tumor microenvironment and p16INK4a -status should stratify patients for separate immunotherapeutic approaches in vSCC. The gene discussed is CDKN2A; the disease is neoplasm.